Please note that effective May 5, 2025, Gilead is transitioning its free drug programs from a retail pharmacy model to a mail order delivery model. All other Advancing Access support offerings will remain the same. For more information, please call 1-800-226-2056.
Support Programs
Our U.S. patient support programs help make prescribed Gilead therapies accessible for individuals who need information regarding insurance and financial support. These programs include:
Gilead HIV Treatment, HIV Prevention and COVID-19 Treatment
Phone: +1-800-226-2056
Gilead Cystic Fibrosis Product
Phone: +1-877-722-9786
Gilead Pulmonary Arterial Hypertension (PAH)
Phone: +1-866-664-5327
Gilead Hepatitis B, Hepatitis C and primary biliary cholangitis
Phone: +1-855-769-7284
Gilead Oncology
Phone: +1-844-876-3358
Kite Oncology
Phone: +1-844-454-KITE (5483)
Gilead’s Advancing Access program helps patients understand their coverage and identify financial support options to access their Gilead HIV treatment, HIV prevention medication and COVID-19 medication. The program offerings include:
- Access to program specialists who can help answer insurance-related questions and provide information regarding coverage options.
- Advancing Access co-pay coupon program, which provides co-pay support for eligible people on HIV treatment and HIV prevention medication with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month.
- The Advancing Access co-pay coupon program also provides Veklury® (remdesivir) co-pay support for eligible people with commercial insurance who need help paying for their out-of-pocket medicine costs for treatment in the outpatient setting.
- The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare and Medicaid. Additional restrictions may apply.
The Advancing Access patient assistance program provides select Gilead medicines at no cost for qualified patients who meet the program's eligibility criteria.
The program supports the following medicines:
- Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide)*
- Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
- Descovy® (emtricitabine/tenofovir alafenamide)*
- Emtriva® (emtricitabine)
- Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)*
- Odefsey® (emtricitabine/rilpivirine/tenofovir alafenamide)*
- Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
- Sunlenca® (lenacapavir)*
- Truvada® (emtricitabine/tenofovir disoproxil fumarate)
- Tybost® (cobicistat)
- Veklury® (remdesivir)*
*Medication offered through the Medication Assistance Program/ Patient Assistance Program (MAP/PAP)
To learn more about the Advancing Access program, visit
or call 1-800-226-2056,
Monday through Friday between 9 a.m. and 8 p.m. EST.
The Cayston Access Program® helps patients understand their coverage and identify financial support options to access Cayston® (aztreonam for inhalation solution). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Cayston co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $10 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid.
- Cayston patient assistance program, which provides Cayston at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about the Cayston Access Program, visit https://www.cayston.com/ or call 1-877-7CAYSTON (877-722-9786), Monday through Friday between 8 a.m. and 8 p.m. EST.
The Letairis® Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis (ambrisentan). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Information about authorized distributors (i.e. participating specialty pharmacies).
- Letairis co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Additional restrictions may apply.
- LEAP patient assistance program provides LETAIRIS at no cost for qualified patients that meet the program’s eligibility criteria.
To learn more about LEAP, visit https://www.letairis.com/patients/ or call 1-866-664-5327, Monday through Friday between 8 a.m. and 8 p.m. EST.
The Support Path® program helps patients understand their coverage and identify financial support options to access their Gilead hepatitis C (HCV) and hepatitis B (HBV) and primary biliary cholangitis (PBC) medicine. The program offerings include:
- Access to program specialists who can help answer insurance-related information and provide questions regarding coverage options.
- Access to the Epclusa nurse educator line.
- Gilead HCV, HBV and PBC co-pay coupon programs, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible HCV patients could pay as little as $5 per month. Eligible HBV patients could pay as little as $0 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Additional restrictions may apply.
- Support Path patient assistance program, which provides Gilead HCV, HBV and PBC medicines at no cost for qualified patients who meet the program’s eligibility criteria.
The Support Path program supports the following medicines:
- Epclusa® (sofosbuvir/velpatasvir)
- Harvoni® (ledipasvir/sofosbuvir)
- Livdelzi® (seladelpar)
- Sovaldi® (sofosbuvir)
- Vosevi® (sofosbuvir/velpatasvir/voxilaprevir)
- Vemlidy® (tenofovir alafenamide)
To learn more about Support Path, visit https://www.mysupportpath.com or call 1-855-769-7284, Monday through Friday between 9 a.m. and 8 p.m. EST.
Gilead Oncology Support program helps patients understand their coverage and identify financial support options to access Trodelvy® (sacituzumab govitecan-hziy). The program offerings include:
- Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
- Co-pay card program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare and Medicaid. Additional restrictions may apply.
- Through the Trodelvy patient assistance program, Trodelvy is provided at no cost for qualified patients who meet the program’s eligibility criteria.
To learn more about Gilead Oncology Support, visit www.gileadoncologysupport.com. or call 1-844-876-3358 Monday through Friday 9:00 a.m. and 7:00 p.m. EST.
Kite Konnect® is committed to helping patients and healthcare teams throughout treatment with CAR T-cell therapy, including:
- Find an authorized CAR T treatment center
- Patient enrollment
- Reimbursement support
- Logistics support